PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.21%
Revenue growth 1.25-1.5x 3141.T's 3.76%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
8.31%
Gross profit growth at 75-90% of 3141.T's 9.49%. Bill Ackman would demand operational improvements to match competitor gains.
25.60%
EBIT growth above 1.5x 3141.T's 0.98%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
27.07%
Operating income growth under 50% of 3141.T's 78.05%. Michael Burry would be concerned about deeper cost or sales issues.
40.70%
Net income growth above 1.5x 3141.T's 19.33%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
40.71%
EPS growth above 1.5x 3141.T's 19.33%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
40.71%
Diluted EPS growth above 1.5x 3141.T's 19.33%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.58%
10Y revenue/share CAGR under 50% of 3141.T's 112.25%. Michael Burry would suspect a lasting competitive disadvantage.
-16.43%
Negative 5Y CAGR while 3141.T stands at 59.99%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
39.52%
3Y revenue/share CAGR above 1.5x 3141.T's 19.08%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
146.54%
Below 50% of 3141.T's 293.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
26.35%
Below 50% of 3141.T's 78.61%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
62.87%
3Y net income/share CAGR above 1.5x 3141.T's 36.25%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
172.32%
10Y equity/share CAGR at 75-90% of 3141.T's 209.77%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
21.13%
Below 50% of 3141.T's 107.70%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
67.38%
3Y equity/share CAGR above 1.5x 3141.T's 24.85%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-25.00%
Cut dividends over 10 years while 3141.T stands at 16127.75%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
50.00%
Below 50% of 3141.T's 236.00%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
38.46%
Below 50% of 3141.T's 90.91%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
23035.00%
Our AR growth while 3141.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.52%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.02%
Asset growth above 1.5x 3141.T's 1.78%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.55%
BV/share growth above 1.5x 3141.T's 3.17%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
1.97%
Debt growth far above 3141.T's 2.21%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-46.41%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.